| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-10 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |